The Phase II study has enrolled 120 women ages 45 and older with stage 0 or stage 1 breast cancer. Recruitment is ongoing at UVA and the study is now enrolling participants at Thomas Jefferson University in Philadelphia as well.
Tag: Precision Breast IORT
Precision Breast IORT is a unique form of IORT developed at UVA — now being examined in a Phase II clinical trial — that incorporates CT imaging and high-dose rate (HDR) brachytherapy.